Metropolitan Life Insurance Co NY reduced its position in Under Armour Inc (NYSE:UA) by 3.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,917 shares of the company’s stock after selling 1,167 shares during the quarter. Metropolitan Life Insurance Co NY’s holdings in Under Armour were worth $640,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in UA. Cerebellum GP LLC grew its holdings in Under Armour by 7.6% in the first quarter. Cerebellum GP LLC now owns 17,899 shares of the company’s stock valued at $338,000 after purchasing an additional 1,262 shares during the last quarter. Meridian Wealth Management LLC acquired a new stake in Under Armour in the first quarter valued at $108,000. Thor Advisors LLC acquired a new stake in Under Armour in the first quarter valued at $29,000. Franklin Street Advisors Inc. NC grew its holdings in Under Armour by 5.4% in the first quarter. Franklin Street Advisors Inc. NC now owns 372,694 shares of the company’s stock valued at $7,033,000 after purchasing an additional 19,140 shares during the last quarter. Finally, ICONIQ Capital LLC acquired a new stake in Under Armour in the first quarter valued at $255,000. 32.36% of the stock is owned by institutional investors and hedge funds.
Several analysts have weighed in on UA shares. Pivotal Research reissued a “hold” rating and issued a $23.00 target price on shares of Under Armour in a report on Tuesday, April 30th. Piper Jaffray Companies set a $30.00 price objective on Under Armour and gave the company a “buy” rating in a research note on Monday, June 24th. JPMorgan Chase & Co. set a $195.00 price objective on bluebird bio and gave the company a “buy” rating in a research note on Friday, May 17th. ValuEngine lowered Valero Energy from a “hold” rating to a “sell” rating in a research note on Wednesday, May 8th. Finally, B. Riley set a $12.00 price objective on Under Armour and gave the company a “sell” rating in a research note on Tuesday, April 9th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $20.50.
Under Armour (NYSE:UA) last released its earnings results on Thursday, May 2nd. The company reported $0.05 earnings per share for the quarter. Under Armour had a return on equity of 7.05% and a net margin of 0.12%. The firm had revenue of $1.20 billion for the quarter. On average, equities analysts forecast that Under Armour Inc will post 0.35 EPS for the current fiscal year.
About Under Armour
Under Armour, Inc, together with its subsidiaries, develops, markets, and distributes branded performance apparel, footwear, and accessories for men, women, and youth primarily in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company offers its apparel in compression, fitted, and loose types to be worn in hot and cold.
Recommended Story: Why is insider trading harmful?
Receive News & Ratings for Under Armour Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Under Armour and related companies with MarketBeat.com's FREE daily email newsletter.